IP Library Granted Patent US 8,734,433
Granted Patent B2
US 8,734,433 · App. 13/691,687 · Granted May 27, 2014

System and method for determining dosimetry in ophthalmic photomedicine

Inventors: Daniel A. Palanker (Sunnyvale, CA); Dan Andersen (Menlo Park, CA)
Assignee: Topcon Medical Laser Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,734,433
App. No.
13/691,687
Granted
May 27, 2014
Kind
B2
Abstract

A system and method for treating ophthalmic target tissue, including a light source for generating a beam of light, a beam delivery system that includes a scanner for generating patterns, and a controller for controlling the light source and delivery system to create a dosimetry pattern of the light beam on the ophthalmic target tissue. One or more dosage parameters of the light beam vary within the dosimetry pattern, to create varying exposures on the target tissue. A visualization device observes lesions formed on the ophthalmic target tissue by the dosimetry pattern. The controller selects dosage parameters for the treatment beam based upon the lesions resulting from the dosimetry pattern, either automatically or in response to user input, so that a desired clinical effect is achieved by selecting the character of the lesions as determined by the dosimetry pattern lesions.

Claims (35)

1. A system for treating ophthalmic target tissue, comprising:

a light source for generating a beam of light;

a beam delivery unit for delivering the beam of light to ophthalmic target tissue, wherein the beam delivery unit includes a scanner unit for deflecting the beam of light;

a controller for controlling at least one of the light source and the beam delivery unit to create a dosimetry pattern of the beam of light on the ophthalmic target tissue for which at least one dosage parameter of the beam of light varies within the dosimetry pattern; and

a visualization device for capturing an image of lesions formed on the ophthalmic target tissue by the dosimetry pattern;

wherein the controller is configured to control at least one of the light source and the beam delivery unit to then deliver a treatment beam of light to the ophthalmic target tissue, the treatment beam of light having at least one dosage parameter thereof selected in response to the captured image of lesions.

2. The system of claim 1 , wherein the controller is configured to make the selection of the at least one dosage parameter in response to a user interface that prompts a user to identify one of the lesions in the captured image as having a particular visible clinical result.

3. The system of claim 1 , wherein the controller is configured to make the selection of the at least one dosage parameter in response to a user interface that prompts a user to identify a number of lesions present in the captured image.

4. The system of claim 1 , wherein the controller is configured to make the selection of the at least one dosage parameter in response to the controller determining one of the lesions in the captured image has a particular visible clinical result.

5. The system of claim 1 , wherein the controller is configured to make the selection of the at least one dosage parameter in response to the controller determining how many lesions are present in the captured image.

6. The system of claim 1 , wherein the controller configuration includes controlling the at least one of the light source and the beam delivery unit to create a treatment pattern of the beam of light on the ophthalmic target tissue having the at least one dosage parameter thereof selected in response to the captured image of lesions.

7. The system of claim 6 , wherein the controller configuration includes controlling the at least one of the light source and the beam delivery unit to create the treatment pattern of the beam of light to produce invisible lesions on the ophthalmic target tissue, and to produce at least one visible lesion that serves as a fiducial mark for visually locating the invisible lesions.

8. The system of claim 1 , further comprising:

a user interface on which the controller is configured to display a visual indicator that visually indicates a desired clinical result of a lesion to be produced by the beam of light on the ophthalmic target tissue.

9. The system of claim 8 , wherein the desired clinical result is at least one of an intensity and size of a lesion produced by the beam of light.

10. The system of claim 8 , wherein the controller is configured to adjust at least one dosage parameter of the beam of light in response to user input on the user interface.

11. The system of claim 8 , wherein the controller is configured to display an additional visual indicator that visually indicates an observed clinical result of a lesion produced by the beam of light on the ophthalmic target tissue.

12. The system of claim 1 , wherein the beam of light is pulsed, and wherein the dosimetry pattern comprises a plurality of discrete spots.

13. The system of claim 1 , wherein the dosimetry pattern comprises a moving spot that scans a straight or curved line.

14. A system for treating ophthalmic target tissue, comprising:

a light source for generating a beam of light;

a beam delivery unit for delivering the beam of light to ophthalmic target tissue, wherein the beam delivery unit includes a scanner unit for deflecting the beam of light;

a controller for controlling at least one of the light source and the beam delivery unit to create a dosimetry pattern of the beam of light on the ophthalmic target tissue for which at least one dosage parameter of the beam of light varies within the dosimetry pattern;

a visualization apparatus for observing lesions formed on the ophthalmic target tissue by the dosimetry pattern; and

a user interface for receiving information about the observed lesions;

wherein the controller is configured to control at least one of the light source and the beam delivery unit to then deliver a treatment beam of light to the ophthalmic target tissue, the treatment beam of light having at least one dosage parameter thereof selected in response to the received information.

15. The system of claim 14 , wherein the information includes an identification of one of the lesions having a particular visible clinical result.

16. The system of claim 14 , wherein the information includes an identification of a number of the lesions formed on the ophthalmic target tissue.

17. The system of claim 14 , wherein the controller configuration includes controlling the at least one of the light source and the beam delivery unit to create a treatment pattern of the beam of light on the ophthalmic target tissue having the at least one dosage parameter thereof selected in response to the received information.

18. The system of claim 17 , wherein the controller configuration includes controlling the at least one of the light source and the beam delivery unit to create the treatment pattern of the beam of light to produce invisible lesions on the ophthalmic target tissue, and to produce at least one visible lesion that serves as a fiducial mark for visually locating the invisible lesions.

19. The system of claim 14 , wherein the user interface is configured to display a visual indicator that visually indicates a desired clinical result of a lesion to be produced by the beam of light on the ophthalmic target tissue.

20. The system of claim 19 , wherein the desired clinical result is at least one of an intensity and size of a lesion produced by the beam of light.

21. The system of claim 19 , wherein the controller is configured to display an additional visual indicator that visually indicates an observed clinical result of a lesion produced by the beam of light on the ophthalmic target tissue.

22. The system of claim 14 , wherein the beam of light is pulsed, and wherein the dosimetry pattern comprises a plurality of discrete spots.

23. The system of claim 14 , wherein the dosimetry pattern comprises a moving spot that scans a straight or curved line.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2021
From: TOPCON MEDICAL LASER SYSTEMS, INC.
To: IRIDEX CORPORATION
Reel/Frame 056836/0849 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2013
From: PALANKER, DANIEL V.; ANDERSEN, DAN
To: TOPCON MEDICAL LASER SYSTEMS, INC.
Reel/Frame 029715/0769 →
Continuity (3)
Division 11939398 · Nov 13, 2007
Provisional Application 60857951 · Nov 10, 2006
Related Publication 20130096542A1 · Apr 18, 2013